Meta-Analyses ThatGuy[A]

Naloxone Distribution in the Community: What a 2025 Review Actually Measured

A 2025 systematic review and meta-analysis asked whether community overdose education and naloxone distribution (OEND) programs reduce opioid overdose deaths. The authors searched several databases for peer-reviewed studies published 2003–2018 (Group 1) and later added studies from 2018–2022 (Group 2), when fentanyl-related deaths rose.

The main outcome was survival immediately following naloxone administration, not deaths averted in a whole population. Group 1 contained 44 studies; 41 reported individual-level outcomes, covering 74,114 participants and 10,328 naloxone administrations with known outcomes. The 98.3% pooled survival estimate (95% CI 97.5–98.8) came from 30 studies of programs serving people who use drugs, not all 44 studies. Other settings gave 95.0% (95% CI 91.4–97.1) for family or other community members and 92.4% (95% CI 88.9–94.8) for police. In Group 2, nine studies met criteria and five entered quantitative analysis, with similar findings.

This is a review of observational program evaluations, not randomized trials. Among 18 studies using passive follow-up, the median share of participants with follow-up data was 10.5%, compared with 74.5% in 12 studies scheduling follow-up. Also, 10 of the 41 individual-level reports omitted some denominators. The newer Group 2 studies were not formally quality-assessed. Missing outcomes could shift the measured survival proportion. Survival after a reported administration is not the same as fewer overdose deaths across a community, and these data cannot isolate a causal population effect.

A useful question is how completely administrations, overdoses, and deaths were counted. The authors argue for community distribution, but this pooled survival proportion alone cannot measure a change in population mortality.

Review: PMID 40133970 · DOI 10.1186/s12889-025-22210-8
Full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC11934755/

What naloxone-program reviews actually count. PMID 40133970 · community-program review. SUBGROUP: 30 studies; Programs serving people who use drugs. SURVIVAL: 98.3%; Reported known outcomes after naloxone. NOT ESTIMATED: Population; Death-rate change. The 44-study review contains 41 individual-outcome reports; this subgroup has 30. Закрыть Открыть: What naloxone-program reviews actually count. PMID 40133970 · community-program review. SUBGROUP: 30 studies; Programs serving people who use drugs. SURVIVAL: 98.3%; Reported known outcomes after naloxone. NOT ESTIMATED: Population; Death-rate change. The 44-study review contains 41 individual-outcome reports; this subgroup has 30.
Original evidence card based on the cited review; the text gives the method and limits.
↑ 1

Обсуждение

Комментарии

1

На каждом уровне сначала старые комментарии; ответы остаются под своим родителем.

Написать Join — чтобы участвовать в обсуждении.

The 10.5% median follow-up in the passive studies is the part that deserves the most weight. If you only learn the outcome for one participant in ten, and the ones you lose track of are plausibly the ones who died, then 98.3% survival is measuring who got recorded, not who survived.